Founders
Founders
Dr Panagiota Kasioumi
BSc Biologist, MSc in Biotechnology, MSc(c) Pharmaceutical Biosciences & Drug Development, PhD in Biology, Cert. Clinical Research Associate (CRA), Cert. Pharmacovigilance and Materiovigilance: Principles and Good Practices for Patient Safety
“The integration of lived experience into scientific knowledge is a key factor in developing a comprehensive approach to pharmacovigilance.“
Maria Karantza
BSc Βιοχημικός, MSc Drug Discovery and Pharma Management
“Clinical trials mark the transition from controlled design to real-world clinical practice. There, systematic pharmacovigilance is fundamental to ensuring patient safety.“
Scientific Associates
Scientific Associates
Alexandros Eleftheriou
MD, BSc Biomedical Sciences
“Confusion between the side effects of a medication and the symptoms of a potential underlying illness is a common occurrence and can ultimately be to the patient's detriment, leading to misjudgements or delays in correct treatment.“
Eirini Hondrou
Pharmacist
Co-founder, Cocoon Lab
MSc in Pharmaceutical Biosciences & Drug Development,
With a specialization in pharmaceutics and a strong interest in drug safety and pharmacovigilance.
“The safe use of medicines is not a single act, but a continuous process of information, monitoring and collaboration.”
Dr Eleni Tsaousi
MSc, PhD Chemist
MEng Materials Science
Medical student
“The safety of medicines is a fundamental pillar of quality healthcare and the protection of public health.”
Dr. Eleni Katsarou
Physicist, MSc in Medical Physics – Radiophysics,
PhD in Medical Physics
Certified Expert in Medical Physics and Radiation Protection
MSc(c) in Biomedical Imaging and Radiation Protection
“The safe integration of medical technology into clinical practice requires scientific evidence, quality assurance and continuous monitoring.“
Ioannins Papachristos
MEng, Biomedical Engineer, UoI PhD(c) in Computational Neuroimaging, UoI/Harvard Science Communication Expert, EU
“Knowledge of medicines is not simply science; it is power that transforms every piece of information into a protective shield, every observation into timely intervention, and every person into an active guardian of their own life.“
Iliana Georgara Kitsou
DVM, MSc Pharmaceutical Biosciences & Drug Development
“Pharmacovigilance is the science that gives voice to safety; it is our commitment to ensuring that every treatment remains beneficial throughout its lifecycle.“
Dr Sofia Gkogkou
PhD, MSc, MSc, Nurse
“In my daily work with patients as a nurse, I find that the use of medication, whilst therapeutically essential, can carry risks, such as side effects, dependency, and withdrawal symptoms.“
Christos Efthimiades
MEng Computer and Information Systems Engineering, MSc(c) in Digital and Soft Skills
“Through modern digital solutions, informatics supports education and the correct understanding of drug safety.“
Leandros Makis
Pharmacist
“As progress in the health sector advances rapidly, continuous training, insight, and adaptation to new data emerge as an undeniable necessity.”
Panagiotis Ferentinos
MD
“An adverse event isn't “minor”.
Such information has the potential to safeguard the health of thousands of individuals.
Don't ignore her. Report her.“
Nikolaos Stefanos Mpastas
BSc Nursing, MSc(c) in Algology and Palliative Care
Researcher in Health Psychology and Public Health
“The safety of a medicine is the cornerstone of therapeutic trust.“
Alexander Kiosse
Nurse
“As a nurse, I know from daily contact with patients that the safe and rational use of medicines is not just knowledge, but an act of responsibility. Proper information is the most powerful tool for preventing errors and protecting every patient.“
Scientific Advisors
Scientific Advisors
Dr Mark Horowitz
MD, PhD Associate Professor of Psychiatry, Adelaide University Visiting Lecturer in Psychopharmacology, King's College London Director, National Psychotropic Deprescribing Clinic (NHS, UK) Lead Author, The Maudsley Deprescribing Guidelines
“It is vital that the long-term safety of medications and their safe discontinuation are given the same attention as the initiation of treatment. Most systems are not adequately organised to effectively monitor these issues, thereby endangering public safety. This is particularly true for antidepressants and other psychiatric medications, where problems associated with their long-term use are primarily highlighted through reports from patients and healthcare professionals. A robust and effective pharmacovigilance system is essential to ensure the protection of public health.”
Dr Kalliroi Ziavrou
BSc, MSc, PhD Chemical Toxicologist
“Medication toxicity is a major public health concern that can arise from incorrect dosing, drug interactions, or medication misuse. Empowering individuals with knowledge about medicines is key to promoting their rational and safe use.“
Dr. Paris Roydos
PhD, MSc Molecular Biologist – Geneticist
“Dr Paris Roidis is a Molecular Biologist – Geneticist, specialising in pharmacogenomics, molecular diagnostics and personalised medicine. As Scientific Director of DNA Therapeutics, he focuses on utilising genetic information for the safer and more effective use of medications, as well as bridging scientific knowledge with daily clinical practice.“
Dr Panagiotis Lekkas
DVM, MSc, PhD
“The rational use of medicinal substances presupposes documented scientific knowledge, understanding of pharmacodynamics and pharmacokinetics, as well as strict adherence to the principles of bioethics and evidence-based medical practice.“
Supporters
Supporters
Greek 
English 